Allenex acquires all remaining minority interests in the group

Allenex AB (publ) (”Allenex”) has signed an agreement to acquire all SSP Primers
AB’s ("SSP Primers") shares in Olerup SSP AB, AbSorber AB, Olerup International
AB and Olerup Inc. The acquisition will make Allenex the sole owner of all
companies in the Allenex group. At the same time, Allenex acquires SSP Primers’
claim on Olerup Inc. of about 4 million SEK. These acquisitions are financed by
loans made available by the company's main bank and by payments from Allenex to
SSP Primers over a period of three years.
Pursuant to the agreement Allenex acquires 9% of Olerup SSP AB, 1.9% of AbSorber
AB, 25% of Olerup International AB and 50% of Olerup Inc., USA. Following the
transaction, Allenex will be in possession of all shares in these companies.
Olerup GmbH, Austria, is a by Olerup International AB wholly owned company and
it will consequently now be fully owned by Allenex, meaning that all group
companies will now be wholly owned by Allenex.
The purchase price for these stock purchases totals 20 million SEK.
The agreement with SSP Primers also stipulates that Allenex acquires SSP
Primers’ claim on Olerup Inc. at a price of 4 million SEK. Under the agreement
SSP Primers waives further demands on Allenex and other companies in the Group,
including accrued interest. The 2014 profits in Olerup SSP AB and Olerup
International AB will belong fully to Allenex. The total purchase price will be
24 million SEK. These acquisitions are financed by a new loan from Allenex’ main
bank, Danske Bank, totaling 10 million SEK. The remaining amount is funded by
Allenex’ cash flow, with payments in three installments of 4 million SEK (Feb
2016), 5 million SEK (Feb 2017) and 5 million SEK (Feb 2018). For the
outstanding future payments, a fixed interest rate of 3%, payable annually in
arrears, has been agreed.

.
Anders Karlsson, CEO of Allenex, comments:
"It is very satisfying that we have been able to acquire all the outstanding
shares in the group. We can now focus on the group as a whole and gain a
simpler, more transparently structured company. We expect to be able to find
synergies to take advantage of while it also becomes easier to understand our
business and evaluate what we do."

This transaction does not lead to any significant organizational changes. If
Allenex had owned all minority interests in 2014, earnings per share would have
been 0.13 SEK, compared to 0.11 SEK without this deal. The return on equity
would have amounted to 7%, vs. 8% without this deal. During the past three
years, an average yearly dividend of approximately 4 million SEK has been paid
to SSP Primers from Olerup SSP and Olerup International. These funds will now
instead remain in the group. As a result of this transaction, interest-bearing
liabilities in Allenex now total 112 million SEK, also including the debt of 14
million SEK to SSP Primers as outlined above.

For more information please contact:

Anders Karlsson, CEO Allenex AB, and ph.: +4670-918 00 10, e-mail:
anders.karlsson@allenex.se

Allenex AB discloses the information provided herein pursuant to the Securities
Markets Act and/or the Financial Instruments Trading Act. The information was
submitted for publication on March 4, 2015, at 08.40 CET. Allenex is a life
science-company that develops, manufacture, market and sell products for safer
transplants of organs and bone marrow on the global market. Allenex is listed on
NASDAQ OMX Stockholm Small Cap (ticker: ALNX). 55 persons are employed in the
Allenex group.